Jule Reitz, Simon Lindner, Stefan Benz, Guido Schwarzer, S. Hetjens, Maurizio Grilli, Christoph Reissfelder, Steffen Seyfried, Florian Herrle
{"title":"局部晚期 UICC III 期结肠癌患者开放式和微创右半结肠切除术的比较:系统综述和个体患者数据元分析方案","authors":"Jule Reitz, Simon Lindner, Stefan Benz, Guido Schwarzer, S. Hetjens, Maurizio Grilli, Christoph Reissfelder, Steffen Seyfried, Florian Herrle","doi":"10.3390/surgeries4040066","DOIUrl":null,"url":null,"abstract":"Despite the development of new technologies and multimodal therapies, improving the prognosis of patients with UICC stage III right colon adenocarcinoma remains challenging. Several randomized controlled trials have shown the oncological non-inferiority of minimally invasive surgery compared to open surgery for colon cancer patients. However, for UICC stage III patients, carrying the highest risk for local recurrence and the worst survival, the evidence remains inconclusive. The aim of this systematic review and individual patient data meta-analysis is to improve the scarce evidence regarding minimally invasive surgery for this subgroup of patients. Data from adult patients with pathologically UICC stage III right adenocarcinoma of the colon will be included. The intervention to be assessed is the minimally invasive right hemicolectomy in comparison with the open procedure. The primary outcome will be the 5-year overall survival. Secondary outcomes will include further long-term outcomes, such as disease-free survival, short term, and histological outcomes. Only randomized controlled trials and quasi-randomized controlled clinical trials will be included. The literature search will be conducted in the following databases: PubMed, CINAHL, Cochrane Trials, ClinicalTrials.gov, and Web of Science. The review will be performed using the Cochrane methodology including GRADE tools. The findings of this meta-analysis will be important for choosing optimal treatment pathways and tailoring of surgical therapy in patients with locally advanced UICC stage III right colon cancer.","PeriodicalId":93623,"journal":{"name":"Surgeries","volume":"22 51","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Comparison between Open and Minimally Invasive Right Hemicolectomies in Patients with Locally Advanced UICC Stage III Colon Cancer: A Protocol for a Systematic Review and an Individual Patient Data Meta-Analysis\",\"authors\":\"Jule Reitz, Simon Lindner, Stefan Benz, Guido Schwarzer, S. Hetjens, Maurizio Grilli, Christoph Reissfelder, Steffen Seyfried, Florian Herrle\",\"doi\":\"10.3390/surgeries4040066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Despite the development of new technologies and multimodal therapies, improving the prognosis of patients with UICC stage III right colon adenocarcinoma remains challenging. Several randomized controlled trials have shown the oncological non-inferiority of minimally invasive surgery compared to open surgery for colon cancer patients. However, for UICC stage III patients, carrying the highest risk for local recurrence and the worst survival, the evidence remains inconclusive. The aim of this systematic review and individual patient data meta-analysis is to improve the scarce evidence regarding minimally invasive surgery for this subgroup of patients. Data from adult patients with pathologically UICC stage III right adenocarcinoma of the colon will be included. The intervention to be assessed is the minimally invasive right hemicolectomy in comparison with the open procedure. The primary outcome will be the 5-year overall survival. Secondary outcomes will include further long-term outcomes, such as disease-free survival, short term, and histological outcomes. Only randomized controlled trials and quasi-randomized controlled clinical trials will be included. The literature search will be conducted in the following databases: PubMed, CINAHL, Cochrane Trials, ClinicalTrials.gov, and Web of Science. The review will be performed using the Cochrane methodology including GRADE tools. The findings of this meta-analysis will be important for choosing optimal treatment pathways and tailoring of surgical therapy in patients with locally advanced UICC stage III right colon cancer.\",\"PeriodicalId\":93623,\"journal\":{\"name\":\"Surgeries\",\"volume\":\"22 51\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgeries\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/surgeries4040066\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgeries","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/surgeries4040066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
尽管新技术和多模式疗法不断发展,但改善 UICC III 期右侧结肠腺癌患者的预后仍是一项挑战。多项随机对照试验表明,与开腹手术相比,微创手术在结肠癌患者的肿瘤治疗中并无劣势。然而,对于局部复发风险最高、生存率最差的 UICC III 期患者,相关证据仍不明确。本系统综述和单个患者数据荟萃分析的目的是改善有关该亚组患者微创手术的稀缺证据。本研究将纳入病理诊断为 UICC III 期右侧结肠腺癌的成年患者的数据。评估的干预措施是微创右半结肠切除术与开放手术的比较。主要结果是 5 年总生存率。次要结果将包括进一步的长期结果,如无疾病生存期、短期结果和组织学结果。研究对象只包括随机对照试验和准随机对照临床试验。文献检索将在以下数据库中进行:PubMed、CINAHL、Cochrane Trials、ClinicalTrials.gov 和 Web of Science。将采用包括 GRADE 工具在内的 Cochrane 方法进行综述。这项荟萃分析的结果将对局部晚期 UICC III 期右侧结肠癌患者选择最佳治疗路径和手术治疗的定制非常重要。
A Comparison between Open and Minimally Invasive Right Hemicolectomies in Patients with Locally Advanced UICC Stage III Colon Cancer: A Protocol for a Systematic Review and an Individual Patient Data Meta-Analysis
Despite the development of new technologies and multimodal therapies, improving the prognosis of patients with UICC stage III right colon adenocarcinoma remains challenging. Several randomized controlled trials have shown the oncological non-inferiority of minimally invasive surgery compared to open surgery for colon cancer patients. However, for UICC stage III patients, carrying the highest risk for local recurrence and the worst survival, the evidence remains inconclusive. The aim of this systematic review and individual patient data meta-analysis is to improve the scarce evidence regarding minimally invasive surgery for this subgroup of patients. Data from adult patients with pathologically UICC stage III right adenocarcinoma of the colon will be included. The intervention to be assessed is the minimally invasive right hemicolectomy in comparison with the open procedure. The primary outcome will be the 5-year overall survival. Secondary outcomes will include further long-term outcomes, such as disease-free survival, short term, and histological outcomes. Only randomized controlled trials and quasi-randomized controlled clinical trials will be included. The literature search will be conducted in the following databases: PubMed, CINAHL, Cochrane Trials, ClinicalTrials.gov, and Web of Science. The review will be performed using the Cochrane methodology including GRADE tools. The findings of this meta-analysis will be important for choosing optimal treatment pathways and tailoring of surgical therapy in patients with locally advanced UICC stage III right colon cancer.